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Highlights 
 
• tert-Butylhydroquinone (TBHQ), a food additive, is assumed to be bioactive. 
• Cellular actions of TBHQ at sublethal levels were examined in rat thymocytes. 
• TBHQ prompted apoptosis process and elevated intracellular Zn2+ levels.  
• Inhibitory and facilitatory actions of TBHQ on H2O2 cytotoxicity were observed. 
• TBHQ at sublethal levels may cause cytoprotective and adverse actions. 
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Abstract 
 
     Tertiary butylhydroquinone (TBHQ) is a food additive that possesses antioxidant activity. 
Its alternative applications have been explored in recent studies. However, there is controversy 
regarding safety. In this study using rat thymocytes, the cellular actions of TBHQ at sublethal 
concentrations were examined. TBHQ at concentrations of 3 µM or more elevated intracellular 
Zn2+ concentration ([Zn2+]i) in a dose-dependent manner, by increasing membrane Zn2+ 
permeability and releasing Zn2+ from cellular stores. TBHQ at 30 µM significantly increased 
side scatter (cell density) and the exposure of phosphatidylserine (PS) on cell membrane 
surfaces. It also decreased cellular glutathione (GSH) content without affecting cell lethality. 
Forward scatter was attenuated by 100 µM TBHQ. Thus, it is considered that TBHQ at 
sublethal concentrations (30 µM or less) exerts some adverse actions on cells. TBHQ at 10–30 
µM attenuated the increase in cell lethality induced by hydrogen peroxide (H2O2), while 
potentiation of H2O2 cytotoxicity by 100 µM TBHQ was observed. The range of concentrations 
of TBHQ from benefit to toxicity under in vitro conditions may be 10–30 µM. Although TBHQ 
exhibits antioxidative actions at concentrations that are lower than those which elicit adverse 
cellular effects, sublethal levels of TBHQ cause some adverse actions that may be clinically 
concerned. 
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1. Introduction 
 
     Tertiary butylhydroquinone (TBHQ, Chemical Abstracts 1948-33-0) is a food additive 
that possesses antioxidant activity.1 The European Food Safety Authority has evaluated the 
toxicity of TBHQ and determined safe levels of TBHQ as a food additive.2 At concentrations 
less than 0.02%, TBHQ extends the shelf life of edible fats and oils.3 In addition, beneficial 
actions of TBHQ as an antioxidant have been reported as follows. Under in vitro conditions, 
TBHQ exhibited protective actions on neuroblastoma SH-SY5Y cells against 6-
hydroxydopamine-induced oxidative stress, on rat striatal slices damaged by quinolinic acid, on 
PC12 cells suffering oxidative stress caused by NaF, and on human keratinocytes under arsenic-
induced stress.4–7 TBHQ under in vivo conditions ameliorated testicular toxicity of 
dibromoacetonitrile, inflammation following brain injury in mice, brain injuries after both 
subarachnoid and cerebral hemorrhage in mice, and doxorubicin-induced cardiotoxicity.8–12 
Thus, it is expected that TBHQ will have clinical applications. However, there is controversy 
regarding the safety of TBHQ because cytotoxic and/or DNA-damaging effects of TBHQ have 
also been documented.13–16 Therefore, it is important to accumulate information on TBHQ-
induced adverse actions under in vitro and in vivo conditions in order to ensure its safe use. 
Recently, it was reported that TBHQ elevated [Zn2+]i in 16HBE cells, stabilizing nuclear factor 
erythroid 2related factor 2 as a result by inhibiting phosphatase activity.17 Our previous studies 
have shown that Zn2+ is a determinant of cytotoxicity induced by clotrimazole, H2O2, 
polysorbate 80, and zinc pyrithione.18–22 For example, ZnCl2 significantly potentiated the 
cytotoxicity of H2O2 while a chelator of intracellular Zn2+ almost completely abolished it.20 Thus, 
the various cellular actions of TBHQ should be explored. In this study, we used flow-cytometric 
techniques with fluorescent dyes to examine the cytotoxic actions of TBHQ in rat thymocytes. 
Second, we examined the cellular actions of TBHQ that were presumably related to the 
mechanism of cytotoxicity. Finally, the range of concentrations of TBHQ transitioning from 
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benefit to toxicity was explored. 
 
2. Materials and methods 
 
2.1. Chemicals 
     TBHQ was purchased from Tokyo Chemical Ind. (Tokyo, Japan). The purity was 99.1%. 
Annexin V-FITC, 5-chloromethylfluorescein diacetate (5-CMF), FluoZin-3-AM, and propidium 
iodide (PI) were supplied by Molecular Probes, Invitrogen (Eugene, OR, USA). Chelators for 
extracellular and intracellular Zn2+ were, respectively, diethylenetriamine-N,N,N′,N′′,N′′-
pentaacetic acid and N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine (DTPA and TPEN; 
Dojindo Molecular Technologies, Inc., Kumamoto, Japan). Unless mentioned, all other reagents 
were products of Wako Pure Chemicals (Osaka, Japan). 
 
2.2. Cell preparation 
     Experiments were performed under the approval (No. 05279) of the Tokushima 
University Committee for Animal Experiments. The thymus glands were obtained from male 
Wistar rats (8–12 weeks old, Charles River Laboratories, Yokohama, Japan) that were 
anesthetized with ether. The number of scarified rats was 14. To dissociate individual cells, the 
glands were triturated in chilled Tyrode's solution (2–4°C) consisting of 150 mM NaCl2, 5 mM 
KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM glucose with 5 mM HEPES and appropriate amount of 
NaOH to adjust pH at 7.3–7.4. The Tyrode's solution containing dissociated cells (cell 
suspension) was incubated at 36–37°C for 1 h before experiments. The cell suspension 
contained trace amounts (216.9 ± 14.4 nM; mean ± standard deviation of six samples) of zinc 
from cell preparation.23 The zinc concentration in distilled water was 3.6 ± 5.0 nM while it was 
32.4 ± 4.0 nM in the case of Tyrode's solution. A flame atomic absorption spectrometer 
equipped with a polarized Zeeman's-effect background corrector (Hitachi Model Z-5300, 
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Hitachi High-Technologies Co., Tokyo, Japan) was used for determination of zinc. A hollow-
cathode lamp of zinc (Hitachi part No. 208-2034) was used as a radiation source.  
     TBHQ (1–100 mM in 2 µL dimethyl sulfoxide) were added to plastic test tubes (Watson 
Bio Lab, Tokyo, Japan; 1.998 mL of cell suspension) for achieving final concentrations of 1–
100 µM by a vortical mixing and then the cells were treated with TBHQ for 1–4 h, depending 
on experimental purpose. Thereafter, a sample from each cell suspension (100 µL) was 
cytometrically analyzed. The starting, sample, and sheath flow rates were manually adjusted to 
set the measurement of 195–205 cells/s and the interval of about 180 µs between measurements 
of forward and side scatters. The measurement started after achieving constant flow of cells. 
Data acquisition from 2500 cells took approximately 15 s. Cell lethality estimated from 2500 
cells was quite similar to that estimated from 10000 cells. Therefore, 2500 cells were enough to 
examine cellular actions of TBHQ. 
     Thymocytes spontaneously undergo apoptosis during the prolonged incubation.24,25 
Experiments, including cell preparation, were performed within 8 h after the dissection of 
thymus from experimental animals to avoid possible contribution of spontaneous apoptosis. 
Therefore, the treatment time of TBHQ should be within 5 h. 
 
2.3. Fluorescence measurement 
     Fluorescence of membrane and cellular constituents was measured with a flow cytometer 
(CytoACE-150; JASCO, Tokyo, Japan) by using fluorescent dyes, and analyzed using the 
JASCO software package.20,26 Chemical reagents, except for fluorescent dyes, exhibited no 
fluorescence under the experimental conditions described. To assess cell lethality, 5 µM PI was 
added to the cell suspension. Because PI stains the DNA of dead cells, the fluorescence detected 
provides information on cell lethality. Phosphatidylserine (PS) exposure on outer membrane 
surfaces, a phenomenon occurring during the early stages of apoptosis, was examined via 
annexin V-binding.27 The cells were treated with FITC-labeled annexin V (10 µl/mL) for 30 
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min before the assessment. FluoZin-3-AM was applied to the cell suspension to monitor the 
change in [Zn2+]i.28 Cells were incubated with 500 nM FluoZin-3-AM for 50–60 min before any 
fluorescence measurement. FluoZin-3 fluorescence, without PI fluorescence, of the cells (living 
cells with intact membranes) was measured. 5-CMF-DA was used to estimate changes in 
cellular GSH content.26 The cells were treated with 1 µM 5-CMF-DA 30 min before 
fluorescence measurement. 5-CMF fluorescence reflects cellular GSH content with a correlation 
coefficient of 0.965. Excitation wavelength for fluorescent probes was 488 nm, and emissions 
were detected at 530 ± 20 nm for FITC, FluoZin-3, and 5-CMF fluorescence, and at 600 ± 20 
nm for PI fluorescence. 
 
2.4. Statistical analysis and presentation 
     Statistical analysis was carried out through Tukey's multivariate analysis. P-values of < 
0.05 indicate statistical significance. Values are expressed as mean and standard deviation of 4–
12 samples. Each experimental series was conducted twice or three times unless stated 
otherwise.  
 
3. Results 
 
3.1. Effect of TBHQ on cell lethality 
     The cells were treated with various concentrations of TBHQ (1–100 µM) for 3 h.  
TBHQ at 100 µM increased the population of cells with PI fluorescence (Fig. 1A and 1B). 
TBHQ at 30 µM or less did not increase the population (Fig. 1C). Thus, a small but significant 
increase in cell lethality was observed in the case of 100 µM TBHQ while the treatment with 1–
30 µM TBHQ for 3–4 h did not significantly increase the cell lethality. 
 (Figure 1 near here) 
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3.2. Effect of TBHQ on forward and side scatters 
     Effects of TBHQ on forward and side scatter were examined since the cytotoxic actions 
of some chemicals that induce apoptosis are associated with changes in these indicators (cell 
size and density, respectively) as assessed via flow cytometry. Treatment of cells with 100 µM 
TBHQ for 3 h slightly decreased the intensity of forward scatter and profoundly raised the 
intensity of side scatter (Fig. 2A). TBHQ at 30 µM or less for 3 h did not affect the intensity of 
forward scatter, although the agent at 100µM significantly attenuated forward scatter (Fig. 2B), 
indicating a decrease in cell size. As to the effect on side scatter, TBHQ at 30–100 µM 
significantly raised the intensity of side scatter while it was not the case for 10 µM TBHQ (Fig. 
2C). 
 (Figure 2 near here) 
 
3.3. TBHQ-induced increase in living cells with exposed PS 
     The attenuation of forward scatter in the presence of 100 µM TBHQ suggested cell 
shrinkage (Fig. 2B). Cell shrinkage is one of the initial events in apoptosis.29 PS exposure on 
outer membrane surfaces, one of events during early stage of apoptosis, was detected using 
annexin V-FITC.27 Treatment with 100 µM TBHQ for 3 h profoundly increased the number of 
living cells with FITC fluorescence (Fig. 1A). FITC fluorescence from the cells indicated 
annexin V-binding to PS exposed on cell membrane surfaces. Thus, treatment with 100 µM 
TBHQ may induce apoptosis in rat thymocytes. The concentration–response relationship for 
TBHQ-induced cellular changes, as determined by PI and annexin V-FITC, is shown in Fig. 3B. 
Threshold TBHQ concentration to increase the number of viable PS-exposing cells was 30 µM 
when cells were treated with TBHQ for 3 h. 
 
3.4. TBHQ-induced change in [Zn2+]i 
     Changes in some cellular parameters precede cell death. The [Zn2+]i is one of them. 30–33 
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Changes in intracellular levels of Zn2+ caused by TBHQ were examined using Zn2+-sensitive 
FluoZin-3 fluorescence. Treatment with 30 µM and 100 µM TBHQ for 1 h profoundly shifted 
the fluorescence histogram to the direction of higher intensity (Fig. 3A). As shown in Fig. 3B, 
there was a dose-dependent augmentation of FluoZin-3 fluorescence by 10–100 µM TBHQ. The 
results suggest that the treatment of rat thymocytes with 10–100 µM TBHQ significantly 
elevated [Zn2+]i in a dose-dependent manner. The threshold TBHQ concentration to increase 
FluoZin-3 fluorescence ([Zn2+]i) was determined to be 3 µM. However, the increase at this 
concentration was very small. 
 (Figure 3 near here) 
 
3.5. Effects of ZnCl2 and Zn2+ chelators on TBHQ-elicited elevation in [Zn2+]i 
     The cell suspension contained a small amount (216.9 ± 14.4 nM) of zinc from the cell 
preparation process.23 To identify the source of Zn2+ responsible for the increase in intracellular 
Zn2+ levels by TBHQ, the effects of 3 µM ZnCl2 and Zn2+ chelators (10 µM DTPA and 10 µM 
TPEN) on TBHQ-induced changes were examined (Fig. 3C). ZnCl2 and Zn2+ chelators were 
added to the cell suspension 1 min before the application of TBHQ. The addition of 3 µM ZnCl2 
raised the control level of FluoZin-3 fluorescence, and 100 µM TBHQ further augmented 
FluoZin-3 fluorescence. The augmentation by TBHQ with ZnCl2 was greater than that without 
ZnCl2. Although the removal of external Zn2+ by DTPA slightly decreased the control level of 
FluoZin-3 fluorescence, TBHQ still augmented the FluoZin-3 fluorescence. The augmentation 
by TBHQ after removal of extracellular Zn2+ was less than that under control conditions. These 
results suggest that TBHQ releases intracellular Zn2+ and increases membrane Zn2+ permeability 
(Zn2+ influx), resulting in elevation of [Zn2+]i. Removal of intracellular Zn2+ by TPEN 
completely abolished the augmentation of FluoZin-3 fluorescence by TBHQ. 
 
3.6. TBHQ-induced change in cellular GSH content 
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     Intracellular release of Zn2+ is associated with oxidative stress that converts thiols to 
disulfide.34,35 Therefore, the changes in cellular thiol content induced by TBHQ were examined 
using 5-CMF fluorescence, an indicator of GSH content. Treatment with TBHQ at 30–100 µM 
for 3 h profoundly shifted the histogram of 5-CMF fluorescence to the direction of lower 
intensity (Fig. 4A). Concentration-related change in the intensity of 5-CMF fluorescence is 
shown in Fig. 4B. Treatment with 10 µM TBHQ for 3 h slightly augmented 5-CMF 
fluorescence. Further increases in the concentration of TBHQ (30–100 µM) produced dose-
dependent attenuation of 5-CMF fluorescence. The attenuation by TBHQ was statistically 
significant. Results suggest that TBHQ at 30–100 µM, but not at 10 µM, significantly decreased 
the cellular content of GSH. 
 (Figure 4 near here) 
 
3.7. Effect of TBHQ on cells under oxidative stress induced by H2O2 
     Cellular thiols are cytoprotective against oxidative stress. Therefore, the decrease in 
cellular GSH content increases cell vulnerability to oxidative stress. Although TBHQ possesses 
antioxidant activity,36 treatment with 100 µM TBHQ increased cell lethality (Fig. 1). This 
finding suggested the possibility that TBHQ might affect the cytotoxicity of H2O2. To test this 
hypothesis, we examined the effect of TBHQ (1–100 µM) on cells suffering from oxidative 
stress induced by 100 µM H2O2. The cells were simultaneously treated with H2O2 and TBHQ 
for 3 h. As shown in Fig. 5, the concentration–response of TBHQ-induced effects resembles a 
reversed bell shape. TBHQ at 10–30 µM attenuated the H2O2-induced increase in cell lethality 
by while it was significantly augmented by a dose of 100 µM.  
(Figure 5 near here) 
 
4. Discussion 
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4.1. Characteristics of cell preparation used in this study 
     Thymocytes were used for this model study of chemical cytotoxicity for the following 
reasons. Thymus is most active during neonatal and pre-adolescent periods and this organ 
begins to atrophy by early teens. It is also the case for rat.37 Since many people are concerned 
about the adverse effects of compounds on the health of their children, the results obtained from 
thymocytes scientifically draw interest of people.  
 
4.2. Cellular adverse actions of sublethal levels of TBHQ 
     Treatment with 30 µM TBHQ significantly augmented the intensity of side scatter of rat 
thymic lymphocytes (Fig. 2). It was shown that the staining with PI correlated with changes in 
forward and side scatter characteristics (decreased and increased intensity, respectively). These 
changes occurred because the dead cells stained with PI became smaller and more granular.38 
However, 30 µM TBHQ significantly increased side scatter intensity without affecting forward 
scatter in cells that were not stained with PI. It is not surprising that cytotoxic chemicals affect 
some cellular parameters in viable cells before or during cell death. In the presence of 30–100 
µM TBHQ, exposure of PS on outer membrane surfaces of living cells was detected as 
augmented side scatter intensity (Fig. 2). Thus, TBHQ at higher concentrations may induce 
apoptosis in rat thymocytes. 
     TBHQ elevated [Zn2+]i (Fig. 4). The threshold concentration of TBHQ to increase [Zn2+]i 
(Fig. 4) was lower than those to augment the intensity of side scatter (Fig. 2) and to increase the 
number of cells expressing PS (Fig. 3). In the presence of ZnCl2, TBHQ further elevated [Zn2+]i 
(Fig. 4). Excessive increase in [Zn2+]i has been reported to induce oxidative stress.22,39 Since 
TBHQ greatly decreased the cellular content of GSH (Fig. 5), the ability to buffer intracellular 
Zn2+ seems to be lost. Therefore, the influx of Zn2+ in the presence of TBHQ may result in the 
elevation of [Zn2+]i, presumably leading to Zn2+-dependent cytotoxicity. 
     The European Food Safety Authority estimated the exposure of TBHQ.40 According to 
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the statement (regulatory maximum level exposure assessment scenario), the 95th percentile 
exposure of TBHQ as a food additive is 0.009–0.555 mg/kg body weight/day in infants (4–11 
months), 0.084–0.798 mg/kg body weight/day in toddlers (12–35 months), 0.116–0.929 mg/kg 
body weight/day in children (3–9 years), and 0.040–0.420 mg/kg body weight/day in 
adolescents (10–17 years). Although it may be unrealistic to predict blood concentration of 
TBHQ from the assessment scenario, it is unlikely that TBHQ as a food additive affects 
thymocytes of infants–children since the minimum in vitro concentration of TBHQ to exhibit 
cellular actions was 3–10 µM (0.49–1.66 mg/L).  
 
4.2. Contrasting actions of TBHQ 
     TBHQ is used as an antioxidant food additive. TBHQ exerts beneficial actions for 
medical purposes because reactive oxygen species are involved in many diseases.41,42 As 
described in the Introduction, many experiments have been performed to prove the beneficial 
actions of TBHQ. However, in this study using rat thymocytes, TBHQ at 10–30 µM seems to 
significantly affect some cellular parameters (Figs. 2–5) related to cytotoxicity. TBHQ use 
resulted in a reversed bell shaped response in cells suffering from oxidative stress induced by 
100 µM H2O2 (Fig. 6). TBHQ at 10–30 µM significantly reduced H2O2-induced cell lethality in 
a dose-dependent manner. This was not the case at a concentration of 100 µM TBHQ. Thus, a 
concentration of 10 µM TBHQ is appropriate to exert an antioxidant effect without affecting 
cell lethality. However, there is another explanation for the protective action of 30 µM TBHQ. 
The treatment with 100 µM H2O2 significantly increases the population of annexin V-positive 
living cells. TBHQ at 30 µM increased the population of annexin V-positive living cells. 
Therefore, the protective action of 30 µM TBHQ may be pseudo. TBHQ is supposed to delay 
the transition from annexin V-positive living cells (apoptotic living cells) and propidium-stained 
cells (dead cells). 
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4.3. Clinical consideration 
     From in vitro and in vivo studies ,4–6,9,11 it is proposed that TBHQ is used as a therapeutic 
agent for brain disorders induced by oxidative stress and hemorrhage-associated brain injuries. 
In this in vitro study, the threshold concentration of TBHQ to induce possible adverse effects 
was 30 µM. Since the range of concentrations of TBHQ from benefit to toxicity under in vitro 
conditions may be 10–30 µM, it may be desirable that blood concentration of TBHQ does not 
exceed 1.66 mg/L. 
     There are experimental limitations on the interpretation on our results. Experiments were 
carried out within 5 h (short period) because of rat thymocytes that are spontaneously undergo 
apoptosis during prolong incubation.24,25 Therefore, the primary use of present results would be 
in understanding cytotoxicity in primary thymocytes under these specific applications although 
the results may reveal new aspects of adverse TBHQ action.  
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Figure legends 
 
Fig. 1 Changes in cell lethality and cell population caused by TBHQ. (A) TBHQ-induced 
change in proportion of cells classified with annexin V-FITC and PI. Effect of 100 µM TBHQ 
on fluorescent cytogram (PI fluorescence versus FITC fluorescence). N: Intact living cells, A: 
Annexin V-positive living cells, P: Annexin V-negative dead cells, and AP: Annexin V-positive 
dead cells. The cytogram was constructed with 2500 cells. (B) TBHQ-induced increase in the 
number of cells exhibiting PI fluorescence. Histogram was constructed with 2000 cells. Dotted 
line under the cytogram indicates cells stained with PI. (C) Change in cell proportions due to 
TBHQ. Column and bar indicate mean (%) and standard deviation of population of four samples. 
The experiment was repeated twice. Asterisks (**) indicate significant difference (P < 0.01) 
between control group (CONTROL) and groups of cells treated with TBHQ. 
 
Fig. 2 Change in cytogram (forward scatter versus side scatter) due to TBHQ. (A) Cytograms in 
absence (left panel) and presence (right panel) of 100 µM TBHQ. The cytogram was 
constructed with 2500 cells. (B and C) Dose-dependent changes in forward and side scatter 
intensity due to TBHQ. Column and bar indicate mean and standard deviation of intensity of 
four samples. The experiment was repeated three times. Asterisks (**) indicate significant 
differences (P < 0.01) between control group (CONTROL) and groups of cells treated with 
TBHQ. 
 
Fig. 3 TBHQ-induced change in FluoZin-3 fluorescence. (A) TBHQ-induced change in 
histogram of FluoZin-3 fluorescence. The histogram was constructed with 2500 cells. (B) 
TBHQ dose-dependent change in mean intensity of FluoZin-3 fluorescence. Column and bar 
indicate mean and standard deviation of intensity of four samples. The experiment was repeated 
twice. Asterisks (**) indicate significant difference (P < 0.01) between control group 
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(CONTROL) and groups of cells treated with TBHQ. (C) Effects of ZnCl2, DTPA, and TPEN 
on the TBHQ-induced augmentation of FluoZin-3 fluorescence. Column and bar indicate mean 
and standard deviation of intensity of four samples. The experiment was repeated twice. 
Asterisks (**) indicate significant difference (P < 0.01) between control group and groups of 
cells treated with TBHQ in absence and presence of ZnCl2, DTPA, or TPEN. 
 
Fig. 4 TBHQ-induced change in 5-CMF fluorescence. (A) TBHQ-induced change in histogram 
of 5-CMF fluorescence. The histogram was constructed with 2500 cells. (B) TBHQ dose-
dependent change in mean 5-CMF fluorescence intensity. Column and bar indicate mean and 
standard deviation of intensity of four samples. The experiment was repeated twice. Asterisks 
(**) indicate significant difference (P < 0.01) between control group (CONTROL) and the 
groups of cells treated with TBHQ. 
 
Fig. 5 Change in lethality of cells treated with H2O2 and TBHQ. Column and bar indicate mean 
and standard deviation (%) of lethality of four samples. The experiment was repeated three 
times. Asterisks (**) indicate significant difference (P < 0.01) between control group and the 
groups of cells treated with TBHQ in the absence and presence of H2O2. Symbol (##) shows 
significant differences between the groups of cells treated with respective concentrations of 
TBHQ in the absence and presence of H2O2. 
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FIGURE 4 
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FIGURE 5 
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FIGURE 6 
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Table 1.  
Fluorescent probes used in this study.  
Fluorescent probes / Manufacture 
 Propidium iodide (PI) / Invitrogen (Eugene, OR, USA) 
 Annexin V-FITC / Invitrogen 
 FluoZin-3-AM / Invitrogen 
 Fluo-3-AM / Dojin Chemical Laboratory (Kumamoto, Japan) 
 5-Chloromethylfluorescein diacetate (5-CMF-DA) / Invitrogen 
 JC-1 / Invitrogen 
 
 
 
 
